Viewing Study NCT01114620


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-01-28 @ 7:27 PM
Study NCT ID: NCT01114620
Status: COMPLETED
Last Update Posted: 2019-11-05
First Post: 2010-04-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None elderly View
None post-marketing View
None H1N1 View
None Clinical trial View
None pandemic influenza View